Unibest
← Back to patent-cliff list

CAS 1202261-55-9

1-(tert-butyl) 3-methyl (3R,5S)-5-(N-isobutyl-1H-benzo[d]imidazole-2-carboxamido)piperidine-1,3-dicarboxylate

Codes: IMARIK-011

Application context (from source-drug indications)

HypertensionImarikiren hydrochlorideDiabetic nephropathyImarikiren hydrochlorideHepatic function declineImarikiren hydrochlorideRenal impairmentImarikiren hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Imarikiren hydrochlorideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Imarikiren hydrochlorideOriginator routesteps: 14total yield: 2.6 g

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.